Register for OBR daily




To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

NLNK $14.99 1.6700 +12.54%
DRNA $4.74 0.4300 +9.98%
ZIOP $5.91 0.4300 +7.85%
ATRA $21.81 1.0000 +4.81%
ARGS $4.69 0.2100 +4.69%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

EXEL $13.35 -2.1300 -13.76%
NWBO $0.57 -0.0493 -7.92%
SPHS $3.08 -0.2200 -6.67%
JUNO $31.30 -2.1200 -6.34%
KITE $56.46 -3.5800 -5.96%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Next > | Last >>

Patient-Centered Approaches to Improving Population Health

(ACCCBuzz) Sept 20, 2016 - An increasingly prevalent term in our health-related vocabulary is “population health.” Every journal or health-related article uses the term as if it is widely understood. So what is it, really? How will we measure it and, more importantly, improve it?
read article 



With a Focus on Real Case Studies, ASH Meeting on Hematologic Malignancies to Address Challenging Patient Care Questions

(ASH) Sept 16, 2016 - This weekend, the American Society of Hematology (ASH) will bring leading experts in hematologic malignancies to Chicago to share the most cutting-edge practices for treating different hematologic malignancies.
read press release 



ASCO Brings Volunteer Advocates and Cancer Priorities to Congress during First Annual “Advocacy Summit”

(ASCO in Action) Sept 19, 2016 - During the upcoming Advocacy Summit, ASCO volunteer advocates will educate policymakers about critical issues affecting patients with cancer and their providers, and ask lawmakers to take action during the current Congressional session to fund and accelerate research, and support a reimbursement system that ensures all patients have access to the full range of services needed in effective cancer care.
read article 



Obamacare Tied to Rise in Mammograms

(U.S. News & World Report/HealthDay News) Sept 20, 2016 - The number of Medicare patients getting mammograms increased slightly, but significantly, in the first three years of U.S. health-care reform, according to a new study.
read article 



NIH Selects Sanford For Grant To Move Cancer Research To Clinical Trials

(Sanford Research) Sept 16, 2016 - The Cancer Biology Research Center at Sanford Research is the recipient of a five-year, nearly $11.7 million grant from the National Institutes of Health to translate laboratory research into clinical trials for head and neck and pediatric cancers.
read corporate press release 



Meeting Patients Where They Are: Liberating Clinical Trials Data Under the Cancer Moonshot

(NCI.gov/Cancer Currents Blog) Sept 16, 2016 - Cancer clinical trials are a critically important step on the pathway for new or improved treatments to make their way to patients in clinics and hospitals in towns and cities across the country.
read article 



Vice President Biden Says Better Data, Computing Make Cancer Beatable

(Wall Street Journal/CIO blog) Sept 19, 2016 - Vice President Joe Biden called Monday for a massive effort to harness the power of data in the fight against cancer, underscoring new specific steps in that effort.
read article (paid subscription required) 



BioLineRx Announces Initiation of Phase 2a Trial of BL-8040 in Combination With KEYTRUDA® (pembrolizumab) for Treatment of Pancreatic Cancer

(Yahoo! Finance) Sept 20, 2016 - BioLineRx Ltd. today announced the initiation of a Phase 2a trial investigating BL-8040 in combination with KEYTRUDA® (pembrolizumab), MSD's anti-PD-1 therapy, in patients with metastatic pancreatic cancer.
read article 



Men with Anxiety Are More Vulnerable To Cancer, Study Says

(Los Angeles Times/Science Now) Sept 20, 2016 - Men over 40 who are plagued with the omnipresent of generalized anxiety disorder are more than twice as likely to die of cancer than are men who do not have the mental affliction, new research finds. But for women who suffer from severe anxiety, the research found no increased risk of cancer death.
read article (free registration required) 



Targeting Fat To Treat Cancer

(Salk Institute) Sept 19, 2016 - Fat isn’t just something we eat: it may also lie at the heart of a new approach to treating cancer.
read press release 



Molecular Switch Controlling Immune Suppression May Help Turn Up Immunotherapies

(UC San Diego Health) Sept 19, 2016 - Researchers at University of California San Diego School of Medicine and Moores Cancer Center have identified a strategy to maximize the effectiveness of anti-cancer immune therapy.
read press release 



Fighting Cancer With Sticky Nanoparticles

(Yale News) Sept 19, 2016 - Sticky nanoparticles that deliver drugs precisely to their targets — and then stay there — could play a crucial role in fighting ovarian and uterine cancers.
read article 



Scientists Spot Genes That Make Some Sarcomas Less Aggressive

(Rice University) Sept 19, 2016 - Scientists at Rice and Duke universities have identified a set of genes they say make sarcoma cells less aggressive. They hope to turn the discovery into new therapeutic approaches to fight metastatic cancers.
read article 



Adding Rituximab to Chemo Ups Event-Free Survival in ALL

(Doctors Lounge/HealthDay News) Sept 19, 2016 - For young adults with acute lymphoblastic leukemia, adding rituximab to chemotherapy is associated with increased event-free survival, according to a study published in the Sept. 15 issue of the New England Journal of Medicine.
read article 



American Association for Cancer Research Releases 2016 Cancer Progress Report: Research is Saving Lives

(AACR) Sept 20, 2016 - Cancer patients are benefiting tremendously from immunotherapeutics; an increasing number of cancer types are being treated successfully; report also highlights Blue Ribbon Panel recommendations for areas of research most likely to accelerate the pace of progress in the future.
read press release 



Large Study Finds No Link Between Vasectomy and Prostate Cancer Risk

(ASCO) Sept 19, 2016 - In a new study, men who underwent vasectomy did not have an increased risk of prostate cancer, nor were they more likely to die from prostate cancer than men who did not receive this procedure. According to the researchers, this is the largest prospective study of vasectomy and fatal prostate cancer to date.
read press release 



ASCO, ASTRO and SSO Update Guideline On Postmastectomy Radiotherapy

(ASTRO) Sept 19, 2016 - Three leading national cancer organizations today issued a joint clinical practice guideline update for physicians treating women with breast cancer who have undergone a mastectomy. The update provides additional considerations for physicians to determine which patients might benefit from postmastectomy radiotherapy (PMRT).
read press release 



Microsoft Develops AI to Help Cancer Doctors Find the Right Treatments

(Bloomberg) Sept 20, 2016 - There are hundreds of new cancer drugs in development and new research published minute to minute, helping doctors treat patients with personalized combinations that target the specific building blocks of their disease. The problem is there's too much to read and too many drug combinations for doctors to choose the best option every time.
read article 



Vice President Biden Announces New Steps to Improve Clinical Trials Essential to Advancing the Cancer Moonshot

(TheWhiteHouse.gov) Sept 16, 2016 - Today, Vice President Joe Biden announced a series of new steps focused on increasing access to information about clinical trials and improving the efficiency of our clinical research system.
read press release 



Novartis Says MS Drug Cut Risk Of Disability Advance In Study

(Reuters) Sept 17, 2016 - Novartis's investigational multiple sclerosis drug cut the risk of disability progression in patients with a tough-to-treat form of the disease versus a placebo, the Swiss company said on Saturday, citing a new analysis of a late-stage trial.
read article 



Delivering Coordinated, High Quality Care For Patients

(CMS.gov/The CMS blog) Sept 19, 2016 - In July 2016, CMS proposed new bundled payment models that continue the Administration’s progress to shift Medicare payments from rewarding quantity to rewarding quality by creating strong incentives for hospitals and clinicians to deliver better care to patients at a lower cost.
read article 



U.S. FDA Approves Bayer Contraceptive Device Kyleena

(Reuters) Sept 19, 2016 - The U.S. Food and Drug Administration approved Bayer AG's hormonal contraceptive device, Kyleena, to prevent pregnancy for up to five years, the German company said on Monday.
read article 



Sarepta Stock Doubles to Highest Since 2002 After Drug Approval

(Bloomberg) Sept 19, 2016 - Sarepta Therapeutics Inc. won U.S. approval for its drug to treat Duchenne muscular dystrophy, a victory for young patients with a form of the deadly muscle disease and their parents after a long and disputed regulatory review.
read article 



Tough New Medical Research Rules Strive For Clarity In Previously ‘Opaque’ World

(Kaiser Health News) Sept 19, 2016 - The new rules are designed to make it easier for researchers to understand what experiments must be included in the federal database. "This has been a very opaque world up until to now," Food and Drug Commissioner Robert Califf said. "These are tremendous changes.”
read article 



EPA Weighs In On Glyphosate, Says It Likely Doesn't Cause Cancer

(NPR/TheSalt) Sept 17, 2016 - The Environmental Protection Agency has issued its own report, and it also concludes that glyphosate is not likely to cause cancer in humans. Outside scientists will review the report in October.
read article